EUVIMEDEUVIMED entdecken
Crossref

A Chimeric Classical Insect-Specific Flavivirus Provides Complete Protection Against West Nile Virus Lethal Challenge in Mice

Hong-Qing Zhang, Na Li, Zhe-Rui Zhang, Cheng-Lin Deng, Han Xia, Han-Qing Ye, Zhi-Ming Yuan, Bo Zhang iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Hong-Qing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan…. Hauptthemen laut MEDLINE: West Nile virus, Flavivirus, West Nile Fever, Aedes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

West Nile virus (WNV), an arthropod-borne flavivirus, can cause severe symptoms, including encephalitis, and death, posing a threat to public health and the economy. However, there is still no approved treatment or vaccine available for humans. Here, we developed a novel vaccine platform based on a classical insect-specific flavivirus (cISF) YN15-283-02, which was derived from Culicoides. The cISF-WNV chimera was constructed by replacing prME structural genes of the infectious YN15-283-02 cDNA clone with those of WNV and successfully rescued in Aedes albopictus cells. cISF-WNV was nonreplicable in vertebrate cells and nonpathogenic in type I interferon receptor (IFNAR)-deficient mice. A single-dose immunization of cISF-WNV elicited considerable Th1-biased antibody responses in C57BL/6 mice, which was sufficient to offer complete protection against lethal WNV challenge with no symptoms. Our studies demonstrated the potential of the insect-specific cISF-WNV as a prophylactic vaccine candidate to prevent infection with WNV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

West Nile virusFlavivirusWest Nile FeverAedesVaccinesAnimalsMiceHumansAntibodies, ViralMice, Inbred C57BL

Stichwörter der Autor:innen

West Nile virusinsect-specific flavivirusvaccine

Substanzen

Antibodies, ViralVaccines

Autor:innen und Institutionen

  • Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • Hubei Jiangxia Laboratory, Wuhan, China.

ORCID-Profile: Bo Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, H. Q., Li, N., Zhang, Z. R., Deng, C. L., Xia, H., Ye, H. Q., Yuan, Z. M., & Zhang, B. (2024). A Chimeric Classical Insect-Specific Flavivirus Provides Complete Protection Against West Nile Virus Lethal Challenge in Mice. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad238

Vancouver

Zhang HQ, Li N, Zhang ZR, Deng CL, Xia H, Ye HQ, et al. A Chimeric Classical Insect-Specific Flavivirus Provides Complete Protection Against West Nile Virus Lethal Challenge in Mice. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad238

BibTeX
@article{Zhang2024,
  author = {Zhang, Hong-Qing and Li, Na and Zhang, Zhe-Rui and Deng, Cheng-Lin and Xia, Han and Ye, Han-Qing and Yuan, Zhi-Ming and Zhang, Bo},
  title = {A Chimeric Classical Insect-Specific Flavivirus Provides Complete Protection Against West Nile Virus Lethal Challenge in Mice},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad238}
}
Kostenlos starten →